141 related articles for article (PubMed ID: 32247608)
1. Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells.
Sumarpo A; Ito K; Saiki Y; Ishizawa K; Wang R; Chen N; Sunamura M; Horii A
Biochem Biophys Res Commun; 2020 Jun; 526(3):586-591. PubMed ID: 32247608
[TBL] [Abstract][Full Text] [Related]
2. ABCB1 Is Upregulated in Acquisition of Taxane Resistance: Lessons from Esophageal Squamous Cell Carcinoma Cell Lines.
Wang R; Sumarpo A; Saiki Y; Chen N; Sunamura M; Horii A
Tohoku J Exp Med; 2016 Dec; 240(4):295-301. PubMed ID: 27941276
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells.
Reed K; Hembruff SL; Laberge ML; Villeneuve DJ; Côté GB; Parissenti AM
Epigenetics; 2008 Sep; 3(5):270-80. PubMed ID: 19001875
[TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.
Sun Z; Yang X; Du F; Shi Y; Sun J; Jia J; Liu C; Xiao Y; Yu J; Zhang X; Yang Y
J Gene Med; 2022 Jul; 24(7):e3434. PubMed ID: 35662334
[TBL] [Abstract][Full Text] [Related]
5. Exploiting epigenetic targets to overcome taxane resistance in prostate cancer.
Cevatemre B; Bulut I; Dedeoglu B; Isiklar A; Syed H; Bayram OY; Bagci-Onder T; Acilan C
Cell Death Dis; 2024 Feb; 15(2):132. PubMed ID: 38346967
[TBL] [Abstract][Full Text] [Related]
6. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
7. Smoothened antagonists reverse taxane resistance in ovarian cancer.
Steg AD; Katre AA; Bevis KS; Ziebarth A; Dobbin ZC; Shah MM; Alvarez RD; Landen CN
Mol Cancer Ther; 2012 Jul; 11(7):1587-97. PubMed ID: 22553355
[TBL] [Abstract][Full Text] [Related]
8. Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.
Kubiliute R; Januskeviciene I; Urbanaviciute R; Daniunaite K; Drobniene M; Ostapenko V; Daugelavicius R; Jarmalaite S
Sci Rep; 2021 Mar; 11(1):6556. PubMed ID: 33753859
[TBL] [Abstract][Full Text] [Related]
9. CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer.
Chen W; Qin Y; Wang D; Zhou L; Liu Y; Chen S; Yin L; Xiao Y; Yao XH; Yang X; Ma W; Chen W; He X; Zhang L; Yang Q; Bian X; Shao ZM; Liu S
PLoS Biol; 2018 Jul; 16(7):e2005869. PubMed ID: 30052635
[TBL] [Abstract][Full Text] [Related]
10. Activation of the
Lombard AP; Lou W; Armstrong CM; D'Abronzo LS; Ning S; Evans CP; Gao AC
Mol Cancer Ther; 2021 Oct; 20(10):2061-2070. PubMed ID: 34326198
[TBL] [Abstract][Full Text] [Related]
11. The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance.
Duran GE; Sikic BI
PLoS One; 2019; 14(1):e0210879. PubMed ID: 30668583
[TBL] [Abstract][Full Text] [Related]
12. A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells.
Rong D; Wang C; Zhang X; Wei Y; Zhang M; Liu D; Farhan H; Momen Ali SA; Liu Y; Taouil A; Guo W; Wang Y; Ojima I; Yang S; Wang H
Cancer Lett; 2020 Oct; 491():36-49. PubMed ID: 32730778
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of
Yang Y; Jia J; Sun Z; Liu C; Li Z; Xiao Y; Yu J; Du F; Shi Y; Sun J; Shui J; Zhang X
Future Oncol; 2021 Jun; 17(18):2351-2363. PubMed ID: 33709789
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate Cancer.
Lombard AP; Liu C; Armstrong CM; Cucchiara V; Gu X; Lou W; Evans CP; Gao AC
Mol Cancer Ther; 2017 Oct; 16(10):2257-2266. PubMed ID: 28698198
[TBL] [Abstract][Full Text] [Related]
15. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract][Full Text] [Related]
16. Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein.
Duran GE; Derdau V; Weitz D; Philippe N; Blankenstein J; Atzrodt J; Sémiond D; Gianolio DA; Macé S; Sikic BI
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1095-1103. PubMed ID: 29675746
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and Noncoding RNAs in Taxane Resistance.
Pucci P; Rescigno P; Sumanasuriya S; de Bono J; Crea F
Trends Pharmacol Sci; 2018 Aug; 39(8):695-709. PubMed ID: 29891252
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma.
Ren J; Wang R; Song H; Huang G; Chen L
Mol Med; 2014 Apr; 20(1):164-78. PubMed ID: 24643460
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.
Kenicer J; Spears M; Lyttle N; Taylor KJ; Liao L; Cunningham CA; Lambros M; MacKay A; Yao C; Reis-Filho J; Bartlett JM
BMC Cancer; 2014 Oct; 14():762. PubMed ID: 25312014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
